Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...

A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not been formally approved and that millions have therefore been vaccinated ...

The European Medicines Agency said the AstraZeneca vaccine is safe, after several EU member states, including Germany, France, Italy, and Spain, suspended its use over reports of blood clots in a ...

On 22 November 2019, the European Medicines Agency (“EMA”) published an updated Annex to the European Commission’s Guidelines concerning excipients in the labelling and package leaflet of ...

Guided by public health interests, the European Medicines Agency has set new standards for clinical trial data transparency by adopting a 2010 policy on access to documents and a 2014 policy on pub ...

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire Thu, Jul 25, 2024, 1:05 PM 7 ...

-- The European Medicines Agency said last week that it was initiating a review of the combined use of agents that block the renin-angiotensin system (RAS). The three classes of RAS-blocking drugs ...

The European Medicines Agency (EMA) has finally joined the discussion on artificial intelligence (AI) and machine learning (ML), releasing a draft ...

SHANGHAI, China & JERSEY CITY, N.J., March 28, 2025--Henlius and Organon announced the European Medicines Agency validates filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11 ...

The European Medicines Agency (EMA) qualifies Unlearn’s PROCOVA™ procedure, which provides the regulatory framework for the application of the TwinRCTs to Phase 2 and 3 clinical trials.

The European Medicines Agency EMA has not 'admitted' that mRNA vaccines are 'experimental' An exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, on ...